Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations

Sexually Transmitted Diseases

Volumn 30, Issue 2, 2003, Pages 124-128

  Sauder, Daniel N ^a   Skinner, Robert B ^b   Fox, Terry L ^c   Owens, Mary L ^c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c 3M COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; ARTICLE; CONDYLOMA; CONTROLLED STUDY; CREAM; DRUG EFFICACY; EPIDEMIC; FEMALE; GENITAL TRACT INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; SEXUALLY TRANSMITTED DISEASE; SKIN ALLERGY; SMOKING; TREATMENT OUTCOME; WART VIRUS;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AMINOQUINOLINES; CONDYLOMATA ACUMINATA; DOUBLE-BLIND METHOD; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; INTERFERON INDUCERS; MALE; TREATMENT OUTCOME;

EID: 0037314594     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200302000-00006     Document Type: Article

References (12)

1. Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134:25-30.
2. Cates W. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999; 26(suppl 4):S2-S7.
3. Stone KM. Human papillomavirus infection and genital warts: update on epidemiology and treatment. Clin Infect Dis 1995; 20(suppl 1):S91-S97.
4. Bosch FX, Manos MM. Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective: International Biological Study On Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87:796-802.
5. Maw RD, Reitano M, Roy M. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998; 9:571-578.
6. Beutner KR, Wiley DJ, Douglas JM, et al. Genital warts and their treatment. Clin Infect Dis 1999; 28(suppl 1):S37-S56.
7. Tyring SK, Arany I, Stanley MA, et al. A randomized controlled molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis 1998; 178:551-555.
8. Tyring SK. Immune-response modifiers: a new paradigm in the treatment of human papillomavirus. Curr Ther Res Clin Exp 2000; 61:584-596.
9. Gollnick H, Barraso R, Jappe U, et al. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day. Int J STD AIDS 2001; 12:22-28.
10. Garland SM, Sellors JW, Wikstrom A, et al. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts-results of an open-label, multicentre phase IIIB trial. Int J STD AIDS 2001; 12:722-729.
11. Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1997; 47(RR 1).
12. O'Mahony C, Law C, Gollnick HPM, Marini M. New patient-applied therapy for anogenital warts is rated favourably by patients. Int J STD AIDS 2001; 12:565-570.